A single mutation G454A in P450 drives pyrethroid resistance in the major malaria vector reducing bed net efficacy

Carlos S. Djoko Tagne,Mersimine F. M. Kouamo,Magellan Tchouakui,Abdullahi Muhammad,Leon J.L. Mugenzi,Nelly M.T. Tatchou-Nebangwa,Riccado F. Thiomela,Mahamat Gadji,Murielle J. Wondji,Jack Hearn,Mbouobda H. Desire,Sulaiman S. Ibrahim,Charles S. Wondji
DOI: https://doi.org/10.1101/2024.04.22.590515
2024-04-23
Abstract:Metabolic resistance to pyrethroids is jeopardizing the effectiveness of insecticide-based interventions against malaria. The complexity of the Africa-wide spatio-temporal evolution of the molecular basis of this resistance, the major genetic drivers should be detected to improve resistance management. Here, we demonstrated that a single amino acid change G454A in the cytochrome P450 drives pyrethroid resistance in vector in East and Central Africa. Polymorphism analysis revealed drastic reduction of diversity of the gene in Uganda (2014) with the selection of a predominant haplotype (90%), exhibited a G454A mutation. However, 6 years later (2020) the Ugandan 454A- haplotype was also predominant in Cameroon (84.6%), but absent in Malawi (Southern Africa) and Ghana (West Africa). comparative heterologous metabolism assays revealed that the mutant-type 454A- (R) allele metabolises type II pyrethroid (deltamethrin) better than the wild-type G454- (S) allele. Transgenic flies expressing the mutant-type 454A- allele were significantly more resistant to both type I and II pyrethroids than the flies expressing the wild-type G454- allele. Genotyping with a newly designed DNA-based diagnostic assay targeting the G454A replacement revealed that this mutation is strongly associated with pyrethroid resistance as mosquitoes surviving pyrethroid exposure were significantly more homozygote resistant (Odds ratio = 567, P<0.0001). Furthermore, Cone test and experimental hut trials showed that 454A- reduces the efficacy of LLINs. The resistant allele (454A) is under directional selection in Eastern and Central Africa, present but not strongly selected in Southern Africa and at very low frequency in West Africa. This study reveals the rapid spread of P450-based metabolic pyrethroid resistance driven by , greatly reducing the efficacy of pyrethroid-based control tools. The new DNA-based assay designed here will add to the toolbox to monitor resistance in the field and improve resistance management strategies.
Genetics
What problem does this paper attempt to address?